Products and compositions

US11987794B2 · kind B2 · utility

Assignee

• Sapience Therapeutics, Inc. · DE

Inventors

• Judith Hauptmann · Berlin, DE
• Dmitry Samarsky · Berlin, DE
• Adrien Weingärtner · Berlin, DE
• Lucas Bethge · Potsdam, DE
• Christian Frauendorf · Berlin, DE
• Alison Gallafent · Berlin, DE

Key dates

• Filing date: Mar 7, 2022
• Grant date: May 21, 2024
• Expiry date: Mar 7, 2042

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12N2320/51
• WIPO field: Biotechnology
• WIPO sector: Chemistry

Abstract

The present invention relates to products and compositions and their uses. In particular the invention relates to nucleic acid products that interfere with target gene expression or inhibit target gene expression and therapeutic uses of such products.